25 April marks World Malaria Day 2014, an occasion for us all to come together to renew our efforts and energise our commitment in fighting malaria. We want to highlight the importance of greater investment in tackling malaria for Tanzanian mothers and newborns.
25 April marks World Malaria Day, an occasion for us all to come together to renew our efforts and energise our commitment in fighting malaria. We want to highlight the importance of greater investment in tackling malaria for Tanzanian mothers and newborns. Malaria in TanzaniaBig challenges remain in the fight against malaria in Tanzania. The World Health Organization estimates nine million cases and 8000 deaths from malaria in Tanzanian in 2012. (1)Tanzania is one of the top 10 countries that together account for about 60% of all malaria deaths in Africa each year (1)Good information that links diagnosis and treatment is limited in Tanzania – we do not know for sure how many patients with confirmed malaria have actually received the antimalarial medicines that they need.It is great to know that excellent progress has been seen in Zanzibar/Unguja Island, which is now on track to achieving the World Health Assembly goal of 75% reduction in malaria mortality by 2015. (1) But the rest of Tanzania is not there yet, and much more needs to be done to protect the women and newborns whose lives are threatened by malaria.Malaria during pregnancyIt is generally well-known across Tanzania that pregnant women have a high risk of getting malaria. (2)In places where malaria is common, adults usually develop a degree of immunity to the disease.But women who are pregnant can lose this immunity, and it is the young, adolescent, and first-time mothers who have the highest risk of malaria and its adverse effects in pregnancy. (2)To make things worse, pregnant women with malaria may have no symptoms of the disease. (3)What happens if a pregnant woman has malaria?Malaria can have a devastating effect on the mother and the newborn infant. Around one in ten pregnant African women may develop anaemia from malaria (4), which is a major cause of pregnancy loss, low birthweight, preterm birth, stillbirth and neonatal mortality. (2,3,4)If a woman has malaria during pregnancy, the risk of having a low birthweight baby is doubled. (4)Malaria-induced low birthweight is estimated to be responsible for around 100,000 infant deaths every year in Africa. (3,5)It is estimated that 11·4% of neonatal deaths and 5·7% of all infant deaths in high-burden malaria areas of Africa are caused by low birthweight due to malaria in pregnancy. (6)For first-time mothers these figures rise to 17.6% of neonatal deaths and 9.8% of infant deaths. (6)How can we protect pregnant women and newborns from malaria?The two key interventions for malaria control in Tanzania are
- Sleeping under an insecticide treated mosquito net (ITN)
- Intermittent preventive treatment of malaria during pregnancy (IPTp)
- The Tanzania National Voucher Scheme/Hati Punguzo programme provides vouchers for all pregnant women and infants who attend health facilities
- The RBM Initiative promotes IPTp among pregnant women
- The Global Malaria Action Plan on universal access to utilisation of prevention measures and advocates that, in malaria endemic areas, every person sleep under an ITN or a household that has been insecticide sprayed, and that every pregnant woman receive at least one dose of IPTp during each of the second and third trimesters of pregnancy
- The complex nature of ANC services and fees is discouraging for some women: participants complained about varied user fees, penalties and punishments for late attendance, and unnecessary referrals, which also had to be paid for (7)
- There are delays in accessing ANC services (8)
- Some women attend their ANC late in pregnancy (8)
- Some clinic staff are not distributing the ITN vouchers at the first ANC visit (8)
- Even at a discounted price some women are not able to afford the nets (2)
- Lack of clean water and cups at some clinics meant that ANC staff sometimes allow the women to swallow the IPTp medicines after leaving the clinic which can lead to treatment delays or treatment non-compliance (7)